Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tandem Mass Spectrometry | 13 | 2024 | 1186 | 2.060 |
Why?
|
Chromatography, High Pressure Liquid | 8 | 2024 | 1535 | 1.570 |
Why?
|
Chromatography, Liquid | 9 | 2024 | 982 | 1.350 |
Why?
|
Busulfan | 3 | 2020 | 258 | 0.910 |
Why?
|
Hyperammonemia | 3 | 2013 | 76 | 0.880 |
Why?
|
Immunoassay | 8 | 2021 | 743 | 0.870 |
Why?
|
Hypokalemia | 1 | 2023 | 153 | 0.820 |
Why?
|
Blood Chemical Analysis | 3 | 2013 | 436 | 0.740 |
Why?
|
Hemolysis | 2 | 2023 | 415 | 0.720 |
Why?
|
Chemistry, Clinical | 2 | 2015 | 64 | 0.720 |
Why?
|
Caffeine | 4 | 2013 | 701 | 0.680 |
Why?
|
Saxitoxin | 2 | 2016 | 65 | 0.660 |
Why?
|
Jaundice | 1 | 2018 | 93 | 0.600 |
Why?
|
Alcoholic Intoxication | 1 | 2018 | 174 | 0.580 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 3 | 2022 | 265 | 0.570 |
Why?
|
Amino Acids | 4 | 2013 | 1703 | 0.550 |
Why?
|
Cotinine | 4 | 2015 | 206 | 0.520 |
Why?
|
Anticonvulsants | 3 | 2024 | 1910 | 0.510 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2016 | 129 | 0.500 |
Why?
|
Lead Poisoning | 2 | 2024 | 323 | 0.480 |
Why?
|
Acetaminophen | 1 | 2018 | 555 | 0.460 |
Why?
|
25-Hydroxyvitamin D 2 | 2 | 2020 | 40 | 0.460 |
Why?
|
Theobromine | 2 | 2013 | 14 | 0.460 |
Why?
|
Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2013 | 23 | 0.450 |
Why?
|
gamma-Glutamyl Hydrolase | 2 | 2010 | 8 | 0.440 |
Why?
|
Hyperlipidemias | 1 | 2018 | 771 | 0.440 |
Why?
|
Methotrexate | 2 | 2010 | 1718 | 0.440 |
Why?
|
Hyperargininemia | 1 | 2012 | 12 | 0.420 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2014 | 219 | 0.400 |
Why?
|
Information Services | 1 | 2013 | 236 | 0.390 |
Why?
|
Resistance Training | 4 | 2018 | 192 | 0.390 |
Why?
|
Argininosuccinic Aciduria | 1 | 2011 | 11 | 0.390 |
Why?
|
Epidemiologic Studies | 1 | 2015 | 677 | 0.380 |
Why?
|
Confusion | 1 | 2013 | 278 | 0.370 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2011 | 72 | 0.370 |
Why?
|
Anesthetics | 1 | 2016 | 523 | 0.370 |
Why?
|
Lead | 3 | 2024 | 879 | 0.360 |
Why?
|
Drug Discovery | 2 | 2019 | 1050 | 0.360 |
Why?
|
Access to Information | 1 | 2013 | 316 | 0.340 |
Why?
|
Saliva | 3 | 2014 | 828 | 0.340 |
Why?
|
Wine | 1 | 2010 | 166 | 0.340 |
Why?
|
Bioterrorism | 2 | 2009 | 144 | 0.340 |
Why?
|
Food Contamination | 1 | 2010 | 191 | 0.320 |
Why?
|
Tryptophan | 1 | 2011 | 480 | 0.320 |
Why?
|
Cacao | 1 | 2009 | 98 | 0.320 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2008 | 91 | 0.310 |
Why?
|
Affect | 4 | 2013 | 1486 | 0.310 |
Why?
|
Epilepsy | 1 | 2024 | 3304 | 0.300 |
Why?
|
Antibodies, Heterophile | 1 | 2008 | 128 | 0.300 |
Why?
|
Goiter | 1 | 2008 | 87 | 0.300 |
Why?
|
Health Services | 1 | 2013 | 750 | 0.300 |
Why?
|
Diabetic Ketoacidosis | 1 | 2011 | 253 | 0.290 |
Why?
|
Iodide Peroxidase | 2 | 2023 | 294 | 0.290 |
Why?
|
Drug Industry | 1 | 2014 | 788 | 0.290 |
Why?
|
Drug Monitoring | 3 | 2024 | 961 | 0.280 |
Why?
|
Cystatin C | 1 | 2008 | 270 | 0.280 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2010 | 646 | 0.280 |
Why?
|
Dehydration | 2 | 2005 | 216 | 0.270 |
Why?
|
Galactosemias | 3 | 2014 | 124 | 0.270 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2010 | 617 | 0.270 |
Why?
|
Interleukin-1beta | 1 | 2012 | 1002 | 0.260 |
Why?
|
Artifacts | 2 | 2012 | 1912 | 0.260 |
Why?
|
Reproducibility of Results | 13 | 2024 | 20119 | 0.260 |
Why?
|
Jewelry | 1 | 2024 | 4 | 0.240 |
Why?
|
Chemistry Techniques, Analytical | 1 | 2005 | 48 | 0.240 |
Why?
|
Osteosarcoma | 1 | 2010 | 896 | 0.240 |
Why?
|
Thyrotropin | 1 | 2008 | 833 | 0.240 |
Why?
|
Information Dissemination | 1 | 2013 | 1129 | 0.240 |
Why?
|
Putrescine | 1 | 2024 | 42 | 0.230 |
Why?
|
Water-Electrolyte Balance | 1 | 2005 | 325 | 0.230 |
Why?
|
Body Water | 1 | 2005 | 340 | 0.230 |
Why?
|
Limit of Detection | 3 | 2016 | 273 | 0.230 |
Why?
|
Interferon-gamma | 1 | 2012 | 3155 | 0.220 |
Why?
|
Interleukin-6 | 2 | 2014 | 3210 | 0.210 |
Why?
|
Vitamin D | 2 | 2017 | 3301 | 0.210 |
Why?
|
False Positive Reactions | 2 | 2018 | 958 | 0.210 |
Why?
|
Tobacco Smoke Pollution | 4 | 2015 | 821 | 0.200 |
Why?
|
Phlebotomy | 1 | 2023 | 137 | 0.200 |
Why?
|
Pyomyositis | 1 | 2022 | 10 | 0.200 |
Why?
|
Humans | 79 | 2024 | 761208 | 0.200 |
Why?
|
Hodgkin Disease | 1 | 2010 | 1379 | 0.200 |
Why?
|
Thiocyanates | 1 | 2022 | 70 | 0.200 |
Why?
|
Chromatography, Ion Exchange | 2 | 2013 | 294 | 0.200 |
Why?
|
Milk Proteins | 2 | 2013 | 162 | 0.190 |
Why?
|
Central Nervous System Stimulants | 2 | 2013 | 1176 | 0.190 |
Why?
|
Human Growth Hormone | 2 | 2018 | 642 | 0.190 |
Why?
|
Homocysteine | 1 | 2005 | 637 | 0.190 |
Why?
|
Calibration | 3 | 2021 | 819 | 0.190 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2021 | 122 | 0.180 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4340 | 0.180 |
Why?
|
UTP-Hexose-1-Phosphate Uridylyltransferase | 2 | 2010 | 68 | 0.170 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 931 | 0.170 |
Why?
|
Acidosis | 1 | 2022 | 269 | 0.170 |
Why?
|
Attention | 3 | 2013 | 2394 | 0.170 |
Why?
|
Baths | 1 | 2019 | 53 | 0.170 |
Why?
|
Dietary Supplements | 4 | 2016 | 3410 | 0.170 |
Why?
|
Sweetening Agents | 2 | 2012 | 290 | 0.170 |
Why?
|
Choice Behavior | 1 | 2005 | 825 | 0.160 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 61 | 0.160 |
Why?
|
Skin Diseases, Bacterial | 1 | 2019 | 67 | 0.160 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8003 | 0.160 |
Why?
|
Gastrointestinal Hormones | 1 | 2019 | 101 | 0.160 |
Why?
|
Exercise | 5 | 2018 | 5874 | 0.160 |
Why?
|
Erythrocyte Count | 1 | 2019 | 157 | 0.160 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2017 | 353 | 0.150 |
Why?
|
Arthritis, Infectious | 1 | 2022 | 347 | 0.150 |
Why?
|
Hemoglobins | 2 | 2019 | 1525 | 0.150 |
Why?
|
Beverages | 3 | 2013 | 821 | 0.150 |
Why?
|
Bone Neoplasms | 1 | 2010 | 2527 | 0.150 |
Why?
|
Acute Kidney Injury | 1 | 2010 | 1923 | 0.150 |
Why?
|
Chlorhexidine | 1 | 2019 | 160 | 0.150 |
Why?
|
Energy Intake | 3 | 2014 | 2133 | 0.150 |
Why?
|
Erythrocyte Indices | 1 | 2019 | 144 | 0.150 |
Why?
|
Osteomyelitis | 1 | 2022 | 407 | 0.150 |
Why?
|
Metabolism, Inborn Errors | 1 | 2020 | 284 | 0.150 |
Why?
|
Seizures | 1 | 2011 | 2965 | 0.150 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3803 | 0.150 |
Why?
|
Osmolar Concentration | 1 | 2018 | 659 | 0.150 |
Why?
|
Body Composition | 6 | 2011 | 2427 | 0.150 |
Why?
|
Cyanosis | 1 | 2017 | 82 | 0.140 |
Why?
|
Hematocrit | 1 | 2019 | 623 | 0.140 |
Why?
|
Prostatic Hyperplasia | 1 | 2021 | 521 | 0.140 |
Why?
|
Anti-Infective Agents, Local | 1 | 2019 | 247 | 0.140 |
Why?
|
Caloric Restriction | 2 | 2011 | 299 | 0.140 |
Why?
|
Adolescent | 16 | 2022 | 88298 | 0.140 |
Why?
|
Ginkgo biloba | 1 | 2016 | 26 | 0.140 |
Why?
|
Hormones | 1 | 2021 | 868 | 0.140 |
Why?
|
Citrulline | 2 | 2014 | 107 | 0.140 |
Why?
|
Diapers, Infant | 1 | 2016 | 3 | 0.140 |
Why?
|
Patients | 1 | 2023 | 906 | 0.140 |
Why?
|
Visual Perception | 1 | 2005 | 1385 | 0.140 |
Why?
|
Solid Phase Extraction | 1 | 2016 | 28 | 0.140 |
Why?
|
Vitamin A | 1 | 2020 | 612 | 0.140 |
Why?
|
Oxyhemoglobins | 1 | 2017 | 212 | 0.140 |
Why?
|
Male | 42 | 2024 | 360693 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 486 | 0.140 |
Why?
|
Disulfides | 1 | 2018 | 463 | 0.130 |
Why?
|
Catheter-Related Infections | 1 | 2019 | 273 | 0.130 |
Why?
|
Blood Gas Analysis | 1 | 2017 | 379 | 0.130 |
Why?
|
Cannabinoids | 1 | 2018 | 172 | 0.130 |
Why?
|
Flagellin | 1 | 2017 | 124 | 0.130 |
Why?
|
Musculoskeletal Diseases | 1 | 2022 | 598 | 0.130 |
Why?
|
Medicine, Traditional | 1 | 2016 | 88 | 0.130 |
Why?
|
Lyme Disease | 1 | 2022 | 631 | 0.130 |
Why?
|
Military Personnel | 5 | 2011 | 1246 | 0.130 |
Why?
|
Vitamin E | 1 | 2020 | 872 | 0.130 |
Why?
|
Genetic Diseases, Inborn | 1 | 2020 | 603 | 0.120 |
Why?
|
Infant | 12 | 2024 | 36169 | 0.120 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5333 | 0.120 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2016 | 156 | 0.120 |
Why?
|
Reference Standards | 3 | 2020 | 1005 | 0.120 |
Why?
|
Oximetry | 1 | 2017 | 459 | 0.120 |
Why?
|
UDPglucose 4-Epimerase | 1 | 2014 | 14 | 0.120 |
Why?
|
Eating | 1 | 2021 | 1535 | 0.120 |
Why?
|
Autoantibodies | 1 | 2023 | 2119 | 0.110 |
Why?
|
Nutrition Surveys | 2 | 2019 | 1723 | 0.110 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2008 | 1933 | 0.110 |
Why?
|
Muscle Strength | 1 | 2018 | 624 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2019 | 1141 | 0.110 |
Why?
|
Double-Blind Method | 9 | 2015 | 12341 | 0.110 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2011 | 241 | 0.110 |
Why?
|
Immunoglobulin A | 1 | 2017 | 979 | 0.110 |
Why?
|
Anesthesia, Local | 1 | 2015 | 277 | 0.110 |
Why?
|
Enteral Nutrition | 1 | 2019 | 794 | 0.110 |
Why?
|
Mitochondrial Proteins | 1 | 2019 | 974 | 0.110 |
Why?
|
Plant Extracts | 1 | 2016 | 496 | 0.110 |
Why?
|
Mucositis | 1 | 2014 | 108 | 0.110 |
Why?
|
Protein Hydrolysates | 1 | 2012 | 7 | 0.100 |
Why?
|
Malabsorption Syndromes | 1 | 2013 | 135 | 0.100 |
Why?
|
Liver Regeneration | 1 | 2014 | 214 | 0.100 |
Why?
|
Enzyme Assays | 2 | 2010 | 104 | 0.100 |
Why?
|
Specimen Handling | 2 | 2023 | 702 | 0.100 |
Why?
|
Bupivacaine | 1 | 2015 | 411 | 0.100 |
Why?
|
Epinephrine | 1 | 2015 | 791 | 0.100 |
Why?
|
Laboratories | 2 | 2020 | 462 | 0.100 |
Why?
|
Growth Disorders | 1 | 2017 | 634 | 0.100 |
Why?
|
Ammonia | 1 | 2012 | 243 | 0.090 |
Why?
|
Mouth Mucosa | 1 | 2014 | 432 | 0.090 |
Why?
|
Satiety Response | 1 | 2011 | 47 | 0.090 |
Why?
|
Alcohol Drinking | 2 | 2016 | 4027 | 0.090 |
Why?
|
Galactokinase | 1 | 2010 | 17 | 0.090 |
Why?
|
Metabolomics | 1 | 2020 | 1658 | 0.090 |
Why?
|
Bumetanide | 1 | 2011 | 98 | 0.090 |
Why?
|
Reference Values | 4 | 2019 | 4921 | 0.090 |
Why?
|
Appetite Regulation | 1 | 2011 | 84 | 0.090 |
Why?
|
Reaction Time | 2 | 2008 | 2087 | 0.090 |
Why?
|
Food Deprivation | 2 | 2008 | 114 | 0.090 |
Why?
|
Cross Infection | 1 | 2019 | 1422 | 0.090 |
Why?
|
Urea | 1 | 2012 | 442 | 0.090 |
Why?
|
Parkinson Disease | 1 | 2024 | 2867 | 0.090 |
Why?
|
Diarrhea | 1 | 2017 | 1316 | 0.090 |
Why?
|
Liver | 2 | 2016 | 7514 | 0.080 |
Why?
|
Xanthines | 1 | 2009 | 120 | 0.080 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 502 | 0.080 |
Why?
|
Kidney | 1 | 2005 | 7033 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1201 | 0.080 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 2010 | 98 | 0.080 |
Why?
|
Child Development | 1 | 2021 | 2302 | 0.080 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2011 | 352 | 0.080 |
Why?
|
Zinc | 1 | 2013 | 672 | 0.080 |
Why?
|
Vulnerable Populations | 1 | 2015 | 706 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2199 | 0.080 |
Why?
|
Ghrelin | 1 | 2011 | 251 | 0.080 |
Why?
|
Immunochemistry | 1 | 2008 | 116 | 0.080 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2009 | 126 | 0.080 |
Why?
|
Leptin | 2 | 2021 | 1595 | 0.080 |
Why?
|
Biochemical Phenomena | 1 | 2008 | 58 | 0.080 |
Why?
|
Anthrax | 1 | 2009 | 83 | 0.080 |
Why?
|
Sleep | 2 | 2018 | 4759 | 0.080 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2009 | 239 | 0.080 |
Why?
|
Anemia, Sideroblastic | 1 | 2009 | 109 | 0.080 |
Why?
|
Child | 12 | 2022 | 80152 | 0.080 |
Why?
|
Motor Activity | 2 | 2008 | 2712 | 0.080 |
Why?
|
Adult | 22 | 2019 | 221119 | 0.070 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2009 | 158 | 0.070 |
Why?
|
Rheumatoid Factor | 1 | 2008 | 184 | 0.070 |
Why?
|
Intestines | 1 | 2017 | 1908 | 0.070 |
Why?
|
Indicators and Reagents | 1 | 2008 | 453 | 0.070 |
Why?
|
Sensitivity and Specificity | 5 | 2017 | 14675 | 0.070 |
Why?
|
Cross-Over Studies | 5 | 2013 | 2082 | 0.070 |
Why?
|
Arousal | 1 | 2013 | 1171 | 0.070 |
Why?
|
Thyroid Function Tests | 1 | 2008 | 288 | 0.070 |
Why?
|
Brain Chemistry | 1 | 2011 | 959 | 0.070 |
Why?
|
Hepatocytes | 1 | 2014 | 1231 | 0.070 |
Why?
|
False Negative Reactions | 1 | 2008 | 573 | 0.070 |
Why?
|
Dietary Proteins | 2 | 2013 | 951 | 0.070 |
Why?
|
Ciprofloxacin | 1 | 2009 | 312 | 0.070 |
Why?
|
Neonatal Screening | 1 | 2011 | 597 | 0.070 |
Why?
|
Triiodothyronine | 1 | 2008 | 492 | 0.070 |
Why?
|
Bilirubin | 1 | 2008 | 436 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2020 | 4190 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2724 | 0.070 |
Why?
|
Observer Variation | 1 | 2012 | 2610 | 0.070 |
Why?
|
Female | 27 | 2024 | 392544 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12976 | 0.060 |
Why?
|
ABO Blood-Group System | 1 | 2008 | 381 | 0.060 |
Why?
|
Sheep | 1 | 2008 | 1436 | 0.060 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2008 | 314 | 0.060 |
Why?
|
Fluorescence Polarization Immunoassay | 1 | 2005 | 9 | 0.060 |
Why?
|
Asthma | 2 | 2015 | 6230 | 0.060 |
Why?
|
Blood Specimen Collection | 2 | 2023 | 238 | 0.060 |
Why?
|
Heat Exhaustion | 1 | 2004 | 13 | 0.060 |
Why?
|
Triglycerides | 2 | 2011 | 2457 | 0.060 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2008 | 1128 | 0.060 |
Why?
|
Fatigue | 1 | 2011 | 1550 | 0.060 |
Why?
|
Creatine | 1 | 2006 | 427 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2014 | 5666 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2010 | 808 | 0.060 |
Why?
|
Young Adult | 9 | 2019 | 59221 | 0.060 |
Why?
|
Alberta | 1 | 2023 | 67 | 0.060 |
Why?
|
Child, Preschool | 6 | 2020 | 42224 | 0.050 |
Why?
|
Suburban Population | 1 | 2023 | 54 | 0.050 |
Why?
|
Infant, Newborn | 4 | 2021 | 26199 | 0.050 |
Why?
|
Kidney Function Tests | 1 | 2005 | 680 | 0.050 |
Why?
|
Poverty | 1 | 2015 | 2691 | 0.050 |
Why?
|
Tanzania | 2 | 2018 | 1390 | 0.050 |
Why?
|
Paper | 1 | 2003 | 84 | 0.050 |
Why?
|
Analysis of Variance | 5 | 2013 | 6223 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2015 | 10756 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1780 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3031 | 0.050 |
Why?
|
Malonates | 1 | 2022 | 43 | 0.050 |
Why?
|
Enzyme Stability | 2 | 2014 | 218 | 0.050 |
Why?
|
Physical Endurance | 1 | 2004 | 366 | 0.050 |
Why?
|
Succinates | 1 | 2022 | 79 | 0.050 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2004 | 269 | 0.050 |
Why?
|
Cyanides | 1 | 2022 | 82 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2016 | 4479 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 3025 | 0.050 |
Why?
|
Antidotes | 1 | 2022 | 138 | 0.050 |
Why?
|
Overweight | 1 | 2012 | 2418 | 0.050 |
Why?
|
Testosterone | 2 | 2010 | 2472 | 0.050 |
Why?
|
Denmark | 1 | 2023 | 770 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2017 | 7851 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9187 | 0.040 |
Why?
|
Time Factors | 6 | 2014 | 39957 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4537 | 0.040 |
Why?
|
Glutarates | 1 | 2022 | 243 | 0.040 |
Why?
|
Sleep Deprivation | 1 | 2007 | 847 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4420 | 0.040 |
Why?
|
Recurrence | 1 | 2012 | 8457 | 0.040 |
Why?
|
Insulin | 2 | 2012 | 6588 | 0.040 |
Why?
|
Patient Readmission | 1 | 2014 | 3265 | 0.040 |
Why?
|
Stress, Physiological | 1 | 2007 | 1405 | 0.040 |
Why?
|
Cognition | 2 | 2008 | 6988 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2008 | 1589 | 0.040 |
Why?
|
Research Design | 1 | 2015 | 6180 | 0.040 |
Why?
|
Muscle, Skeletal | 3 | 2013 | 4947 | 0.040 |
Why?
|
Prospective Studies | 7 | 2024 | 54435 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11101 | 0.040 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2021 | 351 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 833 | 0.040 |
Why?
|
Regression Analysis | 2 | 2005 | 6345 | 0.040 |
Why?
|
India | 1 | 2024 | 2287 | 0.040 |
Why?
|
Blood Glucose | 2 | 2011 | 6392 | 0.040 |
Why?
|
Luminescent Measurements | 1 | 2019 | 340 | 0.040 |
Why?
|
Coronary Disease | 1 | 2012 | 5921 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2004 | 2189 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4851 | 0.040 |
Why?
|
Luminescence | 1 | 2017 | 108 | 0.040 |
Why?
|
Campylobacter | 1 | 2017 | 57 | 0.040 |
Why?
|
Electrochemical Techniques | 1 | 2017 | 93 | 0.040 |
Why?
|
Enteropathogenic Escherichia coli | 1 | 2017 | 26 | 0.040 |
Why?
|
Gastric Emptying | 1 | 2019 | 243 | 0.030 |
Why?
|
Clinical Enzyme Tests | 1 | 2016 | 113 | 0.030 |
Why?
|
Cohort Studies | 5 | 2021 | 41496 | 0.030 |
Why?
|
Anxiety | 1 | 2011 | 4569 | 0.030 |
Why?
|
Cryptosporidium | 1 | 2017 | 41 | 0.030 |
Why?
|
Powders | 1 | 2016 | 80 | 0.030 |
Why?
|
Malaysia | 1 | 2016 | 107 | 0.030 |
Why?
|
Shigella | 1 | 2017 | 68 | 0.030 |
Why?
|
Public Health | 1 | 2009 | 2672 | 0.030 |
Why?
|
Plants, Medicinal | 1 | 2016 | 165 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2004 | 1880 | 0.030 |
Why?
|
Hospitalization | 2 | 2015 | 10707 | 0.030 |
Why?
|
Plant Leaves | 1 | 2016 | 150 | 0.030 |
Why?
|
Consumer Product Safety | 1 | 2016 | 121 | 0.030 |
Why?
|
Placebos | 2 | 2012 | 1666 | 0.030 |
Why?
|
Rotavirus | 1 | 2017 | 109 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2013 | 4822 | 0.030 |
Why?
|
Hazardous Substances | 1 | 2016 | 153 | 0.030 |
Why?
|
Adiponectin | 1 | 2021 | 1107 | 0.030 |
Why?
|
Genome, Human | 1 | 2008 | 4423 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2016 | 525 | 0.030 |
Why?
|
Hypesthesia | 1 | 2015 | 106 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 850 | 0.030 |
Why?
|
Middle Aged | 7 | 2024 | 220853 | 0.030 |
Why?
|
Oxides | 1 | 2016 | 401 | 0.030 |
Why?
|
Linear Models | 1 | 2005 | 5869 | 0.030 |
Why?
|
Phytotherapy | 1 | 2016 | 296 | 0.030 |
Why?
|
Carbon Tetrachloride | 1 | 2014 | 72 | 0.030 |
Why?
|
Toxins, Biological | 1 | 2014 | 60 | 0.030 |
Why?
|
Ubiquitination | 1 | 2019 | 1005 | 0.030 |
Why?
|
Nutritional Status | 2 | 2017 | 1597 | 0.030 |
Why?
|
Ohio | 1 | 2015 | 322 | 0.030 |
Why?
|
Zinc Sulfate | 1 | 2013 | 18 | 0.030 |
Why?
|
Lactulose | 1 | 2013 | 31 | 0.030 |
Why?
|
Syndrome | 1 | 2020 | 3271 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1695 | 0.030 |
Why?
|
Aged | 5 | 2024 | 169288 | 0.030 |
Why?
|
Burkina Faso | 1 | 2013 | 86 | 0.030 |
Why?
|
Hydrocortisone | 2 | 2011 | 1818 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1772 | 0.030 |
Why?
|
Mannitol | 1 | 2013 | 177 | 0.030 |
Why?
|
Calcium Signaling | 1 | 2017 | 731 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 3707 | 0.030 |
Why?
|
Soybean Proteins | 1 | 2013 | 55 | 0.030 |
Why?
|
Erythrocytes | 2 | 2014 | 2413 | 0.030 |
Why?
|
Cyclosporine | 1 | 2015 | 776 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 2013 | 400 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2017 | 503 | 0.020 |
Why?
|
Environment | 1 | 2018 | 1122 | 0.020 |
Why?
|
Depression | 1 | 2011 | 8132 | 0.020 |
Why?
|
Body Weight | 2 | 2017 | 4618 | 0.020 |
Why?
|
Absorptiometry, Photon | 2 | 2008 | 1738 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2465 | 0.020 |
Why?
|
Infant, Premature | 1 | 2021 | 2106 | 0.020 |
Why?
|
Permeability | 1 | 2013 | 721 | 0.020 |
Why?
|
Tacrolimus | 1 | 2015 | 736 | 0.020 |
Why?
|
Leucine | 1 | 2013 | 546 | 0.020 |
Why?
|
Acetonitriles | 1 | 2011 | 54 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2024 | 22174 | 0.020 |
Why?
|
Pregnanetriol | 1 | 2010 | 4 | 0.020 |
Why?
|
Energy Metabolism | 3 | 2008 | 2877 | 0.020 |
Why?
|
17-Ketosteroids | 1 | 2010 | 36 | 0.020 |
Why?
|
Weight Gain | 1 | 2021 | 2349 | 0.020 |
Why?
|
17-alpha-Hydroxyprogesterone | 1 | 2010 | 21 | 0.020 |
Why?
|
Galactosephosphates | 1 | 2010 | 9 | 0.020 |
Why?
|
Brachial Artery | 1 | 2012 | 366 | 0.020 |
Why?
|
Mineralocorticoids | 1 | 2010 | 37 | 0.020 |
Why?
|
Androstenedione | 1 | 2010 | 131 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2011 | 368 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7407 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2011 | 380 | 0.020 |
Why?
|
Hemochromatosis | 1 | 2011 | 174 | 0.020 |
Why?
|
Feces | 1 | 2017 | 1490 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2011 | 392 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1610 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3881 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2014 | 1768 | 0.020 |
Why?
|
Isotope Labeling | 1 | 2011 | 393 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 1963 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6504 | 0.020 |
Why?
|
Glycosylation | 1 | 2012 | 1095 | 0.020 |
Why?
|
Catecholamines | 1 | 2010 | 387 | 0.020 |
Why?
|
Isoenzymes | 1 | 2014 | 1682 | 0.020 |
Why?
|
California | 1 | 2013 | 1431 | 0.020 |
Why?
|
Molecular Structure | 1 | 2013 | 1875 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2015 | 998 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4243 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8837 | 0.020 |
Why?
|
Yeasts | 1 | 2009 | 279 | 0.020 |
Why?
|
Vasodilation | 1 | 2012 | 966 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2013 | 891 | 0.020 |
Why?
|
Sirolimus | 1 | 2015 | 1540 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2013 | 3057 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16575 | 0.020 |
Why?
|
Animals | 5 | 2014 | 168079 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2013 | 1149 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6067 | 0.020 |
Why?
|
Diet, Reducing | 1 | 2011 | 485 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2003 | 4487 | 0.020 |
Why?
|
Physical Fitness | 1 | 2011 | 742 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2012 | 58952 | 0.020 |
Why?
|
Heme | 1 | 2009 | 313 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 208 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3537 | 0.020 |
Why?
|
Bone Development | 1 | 2010 | 472 | 0.020 |
Why?
|
Solubility | 1 | 2008 | 1085 | 0.020 |
Why?
|
Aerosols | 1 | 2009 | 635 | 0.020 |
Why?
|
Muscle Fatigue | 1 | 2006 | 95 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8642 | 0.020 |
Why?
|
Oxygen | 1 | 2017 | 4227 | 0.020 |
Why?
|
Fishes | 1 | 2009 | 600 | 0.020 |
Why?
|
Mice | 2 | 2014 | 81326 | 0.020 |
Why?
|
Inflammation | 2 | 2018 | 10759 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2009 | 1159 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6304 | 0.020 |
Why?
|
Carrier State | 1 | 2009 | 522 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 4015 | 0.020 |
Why?
|
Pain Measurement | 1 | 2015 | 3549 | 0.020 |
Why?
|
Prealbumin | 1 | 2007 | 247 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 415 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10553 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14610 | 0.010 |
Why?
|
Body Mass Index | 2 | 2013 | 12952 | 0.010 |
Why?
|
Mutation | 1 | 2009 | 30002 | 0.010 |
Why?
|
Random Allocation | 1 | 2009 | 2393 | 0.010 |
Why?
|
Recovery of Function | 1 | 2014 | 2981 | 0.010 |
Why?
|
United States | 4 | 2016 | 72339 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9327 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2008 | 2340 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2009 | 1867 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2902 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16952 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2380 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2009 | 2328 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18384 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3727 | 0.010 |
Why?
|
Physical Exertion | 1 | 2004 | 668 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2007 | 970 | 0.010 |
Why?
|
Muscle Contraction | 1 | 2006 | 1200 | 0.010 |
Why?
|
Leg | 1 | 2006 | 1087 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2017 | 4673 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2010 | 2159 | 0.010 |
Why?
|
Androgens | 1 | 2008 | 1283 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3331 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 2011 | 2723 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15308 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7046 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 74239 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1301 | 0.010 |
Why?
|
Health Promotion | 1 | 2012 | 2205 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3821 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15545 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9616 | 0.010 |
Why?
|
Fingers | 1 | 2003 | 506 | 0.010 |
Why?
|
ROC Curve | 1 | 2007 | 3584 | 0.010 |
Why?
|
Depressive Disorder | 1 | 2011 | 3727 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14392 | 0.010 |
Why?
|
Women's Health | 1 | 2008 | 2070 | 0.010 |
Why?
|
Exercise Test | 1 | 2006 | 2165 | 0.010 |
Why?
|
Family | 1 | 2009 | 3192 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12474 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39126 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26071 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 24021 | 0.010 |
Why?
|
Rats | 1 | 2011 | 23704 | 0.010 |
Why?
|
Genetic Variation | 1 | 2008 | 6567 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18220 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 15920 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12159 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2008 | 11476 | 0.000 |
Why?
|
Brain | 1 | 2011 | 27092 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2004 | 64681 | 0.000 |
Why?
|